(Q81241494)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851561%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

title

The JAK2(V617F) mutation may be present several years before the occurrence of overt myeloproliferative disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851561%20AND%20SRC:MED&resulttype=core&format=json

myeloproliferative disorders

7 January 2020

main subject

1 reference

C Bellanné-Chantelot

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851561%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

P Jego

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851561%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

P Lionne-Huyghe

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851561%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

M Tulliez

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851561%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

A Najman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851561%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

French group on myeloproliferative disorders

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851561%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

13 September 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851561%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851561%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851561%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851561%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

450-451

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851561%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404896

7 January 2020

exact match

0 references

cites work

The myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404896

7 January 2021

Genetic and clinical implications of the Val617Phe JAK2 mutation in 72 families with myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404896

7 January 2021

The JAK2V617F mutation is detectable at very low level in peripheral blood of healthy donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404896

7 January 2021

Validation of two clinically useful assays for evaluation of JAK2 V617F mutation in chronic myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404896

7 January 2021

JAK2 (V617F) mutation in healthy individuals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404896

7 January 2021

JAK2(V617F): Prevalence in a large Chinese hospital population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404896

7 January 2021